ti.\*:("Regulation of Brain Functions by Adenosine A2A Receptors: Implication for Therapeutics")
Results 1 to 7 of 7
Selection :
Regulation of Brain Functions by Adenosine A2A Receptors: Implication for TherapeuticsPOPOLI, Patrizia.Current pharmaceutical design. 2008, Vol 14, Num 15, issn 1381-6128, 314 p.Serial Issue
Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric DisordersCUNHA, Rodrigo A; FERRE, Sergi; VAUGEOIS, Jean-Marie et al.Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1512-1524, issn 1381-6128, 13 p.Article
Modulation of Ischemic Brain Injury and Neuroinflammation by Adenosine A2A ReceptorsCHEN, Jiang-Fan; PEDATA, Felicita.Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1490-1499, issn 1381-6128, 10 p.Article
A Critical Evaluation of Adenosine A2A Receptors as Potentially Druggable Targets in Huntington's DiseasePOPOLI, Patrizia; BLUM, David; ROSARIA DOMENICI, Maria et al.Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1500-1511, issn 1381-6128, 12 p.Article
Adenosine A2A Receptor Antagonists and Parkinson's Disease : State of the Art and Future DirectionsSIMOLA, N; MORELLI, M; PINNA, A et al.Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1475-1489, issn 1381-6128, 15 p.Article
An Update on Adenosine A2A-Dopamine D2 Receptor Interactions : Implications for the Function of G Protein-Coupled ReceptorsFERRE, S; QUIROZ, C; WOODS, A. S et al.Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1468-1474, issn 1381-6128, 7 p.Article
A2A Adenosine Receptor and its Modulators : Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and AntagonistsCRISTALLI, G; LAMBERTUCCI, C; MARUCCI, G et al.Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1525-1552, issn 1381-6128, 28 p.Article
